ANB004 is a humanized monoclonal antibody inhibitor that targets IL-17. It is applicable in the study of autoimmune and inflammatory diseases, including multiple sclerosis and rheumatoid arthritis (RA).
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
